Striking the right balance between value and price in pharmaceuticals

SDA Bocconi Insight - Zoom On - C. Jommi

SHARE ON

Last summer, Decree 9 of August 2019 was published in the Official Gazette, which revised the system for regulating drug pricing in Italy (Price Decree). The Italian Drug Agency (AIFA) held a public consultation, which wrapped up in September, to discuss guidelines consequent to the new legislative initiative during which drug companies submitted documentation to substantiate requests on eligibility for reimbursement and prices of their products. CERGAS (the Italian Research Center for Healthcare Management) at SDA Bocconi School of Management participated in this public consultation with a document in which, in addition to offering certain technical observations, underscored the importance of making decisions based on a structured and reproducible assessment of the value of new pharmaceuticals.

READ MORE ON SDA BOCCONI INSIGHT>>

 

Related News

11 April 2022
Alira Health Competition: the winner is… ...
Alira Health Competition: the winner is… MIHMEP 23!
Learn More
04 April 2022
Marinella: style, passion and strategy made ...
Marinella: style, passion and strategy made in Naples
Two generations from the company meet the MISA
Learn More
14 February 2022
Relationships in capitalism. An interview ...
Relationships in capitalism. An interview with Professor Giovanni Bazoli
EMF - Executive Master in Finance
Learn More

Related Programs

Management della farmacia Governare l’evoluzione del mercato e massimizzare il valore del proprio punto vendita
  • Start date
  • Duration
  • Format
  • Language
  • 6 Mar 2023
  • 5 days
  • Blended
  • Italian

Per aiutarti a trovare le soluzioni adeguate in un’ottica di lungo periodo nella gestione del punto di vendita di prodotti e servizi per la salute.